Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 3 Pancreatic Neoplasms 2 Carcinoma, Hepatocellular 2 Breast Neoplasms 2 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Thyroid Nodule 1 Prostatic Neoplasms 1 Pancreatic Cyst 1 Liver Neoplasms 1 Glioblastoma 1 Disease 1 Depression 1 Colorectal Neoplasms 1 Camurati-Engelmann Syndrome 1 Breast Cancer Female 1 Brain Neoplasms 1 Astrocytoma 1 Anxiety Disorders 1

Interventions

Therapeutics 21 Psychiatric Rehabilitation 20 Surveys and Questionnaires 7 Early Intervention, Educational 6 Counseling 6 Yoga 5 Psychosocial Intervention 5 Cognitive Behavioral Therapy 5 Behavior Therapy 5 Mindfulness 4 Ketamine 4 Exercise 4 Escitalopram 4 Acupuncture Therapy 4 Saline Solution 3 Psilocybin 3 Mindfulness-Based Stress Reduction 3 Mindfulness-Based Cognitive Therapy 3 Methods 3 Exercise Therapy 3 Control Groups 3 Citalopram 3 Chemotherapy, Adjuvant 3 Sugars 2 Sertraline 2 Palliative Care 2 Observation 2 Niacin 2 Mental Status and Dementia Tests 2 Interviews as Topic 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Depression × Drug Delivery Systems × Clear all

NCT01701284 2023-11-18

rTMSinCP

Northwestern University

Phase NA Completed

Anxiety Disorders, Depression

Data powered by HemOnc (CC BY 4.0) Colophon ⚡